Comparative Effectiveness of Medical Treatments
Editat de Peter Villa, Sophia Brunen Limba Engleză Paperback – 18 aug 2009
Preț: 298.48 lei
Preț vechi: 407.02 lei
-27% Nou
Puncte Express: 448
Preț estimativ în valută:
57.12€ • 59.13$ • 48.28£
57.12€ • 59.13$ • 48.28£
Carte disponibilă
Livrare economică 13-27 februarie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781607411093
ISBN-10: 1607411091
Pagini: 96
Ilustrații: tables & charts
Dimensiuni: 154 x 225 x 8 mm
Greutate: 0.2 kg
Editura: Nova Science Publishers Inc
ISBN-10: 1607411091
Pagini: 96
Ilustrații: tables & charts
Dimensiuni: 154 x 225 x 8 mm
Greutate: 0.2 kg
Editura: Nova Science Publishers Inc
Cuprins
Preface; Research on the Comparative Effectiveness of Medical Treatments: Options for an Expanded Federal Role before the Subcommittee on Health Committee on Ways & Means; Producing Comparative-Effectiveness Information before the Subcommittee on Health, Committee on Ways & Means, U.S. House of Representatives; Testimony of Steven M. Teutsch, Outcomes Research, External Medical & Scientific Affairs, Merck & Co., Inc. Before the House Ways & Means Health Subcommittee, 12 June 2007 Concerning Effectiveness; House Committee on Ways & Means, Statement of Carolyn M. Clancy, Agency for Healthcare Research & Quality, Rockville, Maryland, Testimony before the Subcommittee on Health of the House Committee on Ways & Means, 12 June 2007; House Committee on Ways & Means, Statement of David Dale, American College of Physicians, Testimony before the Subcommittee on Health of the House Committee on Ways & Means, 12 June 2007; House Committee on Ways & Means, Statement of Gail Shearer, Health Policy Analysis, Consumers Union, Testimony before the Subcommittee on Health of the House Committee on Ways & Means, 12 June 2007; House Committee on Ways & Means, Statement of Susan Hearn, Environment Health & Safety, Dow Chemical Company, Midland, Michigan, Testimony Before the Subcommittee on Health of the House Committee on Ways & Means, 12 June 2007; House Committee on Ways & Means, Statement of the Honourable Thomas Allen, A Representative in Congress from the State of Maine, Testimony before the Subcommittee on Health of the House Committee on Ways & Means, 12 June 2007; Background to Hearing on Strategies to Increase Information on Comparative Clinical Effectiveness from House Ways & Means Health Subcommittee Chairman Pete Stark; Index.